Flashback Foreword: KRAS Is a Selection Marker for Panitumumab Benefit in Patients With Metastatic Colorectal Cancer. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Ko AH

Publication

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication ID (Profile URL)

https://researcherprofiles.org/profile/410622473

Publication Year

2023

PubMed ID

37315388

Publication Title

Ko AH. Flashback Foreword: KRAS Is a Selection Marker for Panitumumab Benefit in Patients With Metastatic Colorectal Cancer. J Clin Oncol. 2023 06 20; 41(18):3275-3276.